BIO-Europe Spring® 2012 sets new benchmark in attendance and partnering productivity
EBD Group, the leading partnering firm for the life science industry, today announced that the sixth annual BIO-Europe Spring® international partnering conference was attended by 2,157 delegates from 1,304 companies who engaged in 11,172 one-to-one meetings facilitated by partneringONE®.
The event also featured a dynamic program with 135 company presentations, and panels and workshops delivered by leading industry executives and thought leaders.
Coverage of BIO-Europe Spring can be found on www.partneringnews.com.
“We had a robust turnout this year, including a strong showing by international delegations at BIO-Europe Spring. We are especially grateful to our hosts, the Amsterdam BioMed Cluster and Life Sciences Health for their contribution to the program and in bringing Amsterdam’s cutting-edge scientific innovation to the forefront,” said Carola Schropp, President of EBD Group. “The demand for one-to-one partnering meetings in the life sciences is growing, and remains the primary reason behind the success of BIO-Europe Spring this year.”
A highlight of the conference was the announcement by Johnson &Johnson, GlaxoSmithKline and Index Ventures of a novel EUR 150 million collaborative investment fund to benefit pre-competitive biotech innovation. Read more about the announcement here:http://bit.ly/GOunDc
Other highlights of the program included a welcome by Amsterdam Mayor Eberhard van der Laan, followed by a keynote address on recent Dutch biotech deals in the Netherlands’ dynamic regional sector. The opening plenary addressed orphan indications as one viable model for drug development. This discussion focused on development strategies for orphan drugs and the future of personalized medicine. Read more about the plenary session here:http://bit.ly/H7TzEj
Overall, the high level of activities at BIO-Europe Spring worked to keep delegates involved and engaged with their industry collaborators from the one-to-one partnering meetings and program offerings, to exhibitor receptions and evening events. BIO-Europe Spring 2013 will be held in Barcelona, Spain, March 11–13, 2013. For additional coverage including videos of BIO-Europe Spring 2012, go to the event details on partnering360® athttp://www.partnering360.com/media or at www.ebdgroup.com/bes/index.php.
Additional links and information:
Follow BIO-Europe Spring 2012 on Twitter: twitter.com/EBDgroup (hashtag: #BES12)
LinkedIn Event site: http://linkd.in/uA0L0x
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
About BIO-Europe Spring® 2014
As the springtime counterpart to BIO-Europe®, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s acclaimed partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.
In addition to productive partnering, BIO-Europe Spring offers high level workshops, panels, company presentations, and a lively exhibition. The program features executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative start-ups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy.
Combined, these elements create an insightful and productive event that will have you coming back year after year.
BIO-Europe Spring is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Industry Organization (BIO).
Follow BIO-Europe Spring 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BES14). Or log on to the BIO-Europe Spring 2014 Discussion Forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe Spring.